📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Tolvaptan- and Tolvaptan-Metabolite-Responsive T Cells in Patients with Drug-Induced Liver Injury (2020)

First Author: Gibson A

Attributed to: Definition of the naturally-processed drug-peptide adducts that can act as functional T-cell antigens funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acs.chemrestox.0c00328

PubMed Identifier: 33085478

Publication URI: http://europepmc.org/abstract/MED/33085478

Type: Journal Article/Review

Parent Publication: Chemical Research in Toxicology

Issue: 11

ISSN: 0893-228X